An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting

Antiangiogenic Therapy for High-Grade Gliomas

(2012) Marc Chamberlain et al.   CNS & Neurological Disorders-Drug Targets

Epilepsy in the cancer patient

(2011) Odysseas Kargiotis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies

(2011) Manmeet S Ahluwalia   Expert Review of Anticancer Therapy

Dendritic cell vaccines to combat glioblastoma

(2010) Christopher J Wheeler   Expert Review of Neurotherapeutics

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

(2010) James R. Perry et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of irradiation on tumor cell survival, invasion and angiogenesis

(2010) Odysseas Kargiotis et al.   JOURNAL OF NEURO-ONCOLOGY

Frequent abnormalities of the immune system in gliomas and correlation with the WHO grading system of malignancy

(2010) K. Gousias et al.   JOURNAL OF NEUROIMMUNOLOGY

Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab

(2010) M. Prados et al.   NEURO-ONCOLOGY

Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide

(2010) George C. Bobustuc et al.   NEURO-ONCOLOGY

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

(2009) B. Neyns et al.   ANNALS OF ONCOLOGY

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

(2009) Alessandra Fabi et al.   BMC CANCER

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

(2009) D A Reardon et al.   BRITISH JOURNAL OF CANCER

Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma

(2009) Marc C. Chamberlain et al.   CANCER

Viruses, gene therapy and stem cells for the treatment of human glioma

(2009) A P Kyritsis et al.   CANCER GENE THERAPY

Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss

(2009) M. Snuderl et al.   CLINICAL CANCER RESEARCH

Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma

(2009) Jennifer A. Quinn et al.   JOURNAL OF CLINICAL ONCOLOGY

End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria

(2009) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor initiating cells in malignant gliomas: biology and implications for therapy

(2009) Costas G. Hadjipanayis et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities

(2009) George A. Alexiou et al.   JOURNAL OF NEURO-ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab

(2009) Eudocia C. Quant et al.   NEURO-ONCOLOGY

Bevacizumab and irinotecan for recurrent oligodendroglial tumors

(2009) S. Taillibert et al.   NEUROLOGY

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours

(2008) Hans Skovgaard Poulsen et al.   ACTA ONCOLOGICA

Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience

(2008) Silvia Scoccianti et al.   ANTI-CANCER DRUGS

Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors

(2008) Felix Bokstein et al.   CANCER

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas

(2008) A. Desjardins et al.   CLINICAL CANCER RESEARCH

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments

(2008) A. A. Brandes et al.   CLINICAL CANCER RESEARCH

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

(2008) Teri N. Kreisl et al.   JOURNAL OF CLINICAL ONCOLOGY

Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety

(2008) Tyler Y. Kang et al.   JOURNAL OF NEURO-ONCOLOGY

ACNU-based chemotherapy for recurrent glioma in the temozolomide era

(2008) Caroline Happold et al.   JOURNAL OF NEURO-ONCOLOGY

CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma

(2008) Marc C. Chamberlain et al.   JOURNAL OF NEURO-ONCOLOGY

Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma

(2008) J. F. de Groot et al.   JOURNAL OF NEURO-ONCOLOGY

A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme

(2008) Camilo E. Fadul et al.   JOURNAL OF NEURO-ONCOLOGY

An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma

(2008) Andrew D. Norden et al.   JOURNAL OF NEURO-ONCOLOGY

A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma

(2008) Maria Grazia Fabrini et al.   JOURNAL OF NEURO-ONCOLOGY

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

(2008) Ashwatha Narayana et al.   JOURNAL OF NEUROSURGERY

Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme

(2008) Vinay K. Puduvalli et al.   NEURO-ONCOLOGY

Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

(2008) Kathleen R. Lamborn et al.   NEURO-ONCOLOGY

Experience with irinotecan for the treatment of malignant glioma

(2008) James J. Vredenburgh et al.   NEURO-ONCOLOGY

Colon perforation during antiangiogenic therapy for malignant glioma

(2008) Andrew D. Norden et al.   NEURO-ONCOLOGY

New (alternative) temozolomide regimens for the treatment of glioma

(2008) Wolfgang Wick et al.   NEURO-ONCOLOGY

Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence

(2008) A. D. Norden et al.   NEUROLOGY

Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma

(2008) O Kargiotis et al.   ONCOGENE